Searchable abstracts of presentations at key conferences in endocrinology

ea0019p10 | Bone | SFEBES2009

Bone mineral density and body composition in adult men and women with CAH hyperplasia: congenital adrenal hyperplasia adult study executive

Han T , Willis D , Wild S , Ross R , Conway G , CAH Adult Study Executive CaHASE

Objectives: To assess bone mineral density (BMD) and body composition in adults with congenital adrenal hyperplasia (CAH).Setting: Endocrine clinics in seventeen centres throughout the UK participating in CaHASE, a Society for Endocrinology project.Study design and subjects: Cross-sectional survey of 203 adults with CAH (65 men, 138 women: median age 33 (range 18–70) years). Hundred and sixty six patients were classified as cl...

ea0019p114 | Cytokines and growth factors | SFEBES2009

Expression and purification of a potential long-acting leptin agonist

Carpenter B , Pradhananga S , Wilkinson I , Justice S , Artymiuk P , Ross R

Background: Leptin is an important regulator of the immune response. Therapeutics that modulate leptin signalling are considered to be a potential targets in a number of immune related conditions. The role of leptin antagonists to suppress the immune system, slowing the progression of autoimmune diseases is a widely discussed idea. However, leptin agonists may also be useful to up-regulate the immune response during malnutrition. The aim of this project was to develop long-las...

ea0019p169 | Endocrine tumours and neoplasia | SFEBES2009

Overexpression of human RAMP3 (receptor activity-modifying protein-3) in E. coli and mammalian cells

Kaabi Y , Wilkinson I , Carpenter B , Richards G , Skerry T , Ross RJ

Introduction: RAMPs (receptor activity-modifying proteins) are single-pass transmembrane accessory proteins required for appropriate signalling of the G-protein coupled receptors; CRLR (Calcitonin receptor like receptor) and CTR (Calcitonin receptor). There are three forms of human RAMPs known as, RAMP1, 2 and 3. RAMP3 heterodimerises with CRLR or CTR to form a high affinity receptor for the peptide hormones adrenomedullin and amylin, respectively. However, the exact mechanism...

ea0019p286 | Reproduction | SFEBES2009

Inhibin B and AMH are NOT predictors of serum testosterone in young men after cancer

Greenfield DM , Walters SJ , Ross RJM , Coleman RE , Hancock BW , Snowden JA , Ledger WL

Background: In men inhibin B is correlated with sperm count, concentration and testicular volume. Anti-müllerian hormone (AMH) is significantly positively correlated with inhibin B and significantly negatively correlated with FSH. Raised FSH is a traditional marker of infertility. Young male cancer patients treated with gonadotoxic agents are at high risk of hypogonadism (HG). The relationship between inhibin B and AMH with serum total testosterone is unclear.<p class...

ea0015p106 | Cytokines and growth factors | SFEBES2008

Expression and purification of the leptin receptor

Carpenter Byron , Wilkinson Ian , Wu Zida , Strasburger Christian , Artymiuk Peter , Ross Richard

Background: Leptin has multiple functions including modulating energy homeostasis and the immune response. Leptin is an important target for therapy to modulate the immune response in several autoimmune diseases. Although the structure of leptin is known, that of its receptor remains unsolved. The aim of this project was to express and purify the extracellular domain the leptin receptor (ObR) in order to carry out functional and crystallisation studies to elucidate the mechani...

ea0012p43 | Diabetes, metabolism and cardiovascular | SFE2006

What is the relationship between testosterone and fat mass in young male cancer survivors and healthy controls?

Greenfield DM , Walters SJ , Eastell R , Coleman RE , Hancock BW , Snowden J , Ross RJ

Background and AimIt is known that the variability of testosterone concentrations is predictive of both truncal and peripheral obesity in healthy men. The aim of this study was to establish the nature of the relationship between testosterone and fat mass in young male cancer survivors compared with healthy controls.Subjects176 male cancer survivors (mean age 37.3 years SD 5.8) who previously received gonadoto...

ea0012p47 | Diabetes, metabolism and cardiovascular | SFE2006

Women gain weight and fat mass despite lipectomy at abdominoplasty and breast reduction

Bulugahapitiya DUS , Rinomhota AS , French SJ , Siyabalapitiya S , Caddy CM , Griffith RW , Ross RJ

ObjectivesRemoval of fat results in compensatory weight gain in animals. The objective of this study was to examine changes in weight and fat mass in patients who underwent lipectomy at abdominoplasty and bilateral breast reduction.MethodsIn a retrospective analysis, weight changes in 16 patients who had abdominoplasty and 17 patients who received bilateral breast reduction surgery were compared with 16 patie...

ea0012p79 | Pituitary | SFE2006

Combining GHRH/Arginine with a synacthen test diminishes the cortisol response

Siyambalapitiya S , Bulugahapitiya DUS , Ibbotson V , Doane A , Ghigo E , Campbell MJ , Ross RJ

Rationale, aims and objectivesThe GHRH/Arginine and Short Synacthen Tests (SST) have been validated as safer alternatives to the Insulin Tolerance Test for the assessment of the growth hormone reserve and Hypothalamic-Pituitary-Adrenal axis integrity, respectively. However, these two tests are performed separately. The objective of this study was to see whether the synacthen and GHRH/Arginine tests could be combined to save time, blood samples and minimi...

ea0011p237 | Cytokines and growth factors | ECE2006

Growth hormone receptor extracellular domain linked to glycophosphatidyl inositol (GHR-GPI); a potential growth hormone receptor antagonist

Bowles CE , Wilkinson I , Gavalas N , Watson P , Watts D , Ross R

Introduction: The growth hormone receptor (GHR) consists of 620 residues and belongs to the class I cytokine receptor family. It is a single membrane spanning protein that binds its ligand, GH, via the extracellular domain. GH binding to GHR induces a conformational change in the preformed receptor dimer, which leads to intracellular signalling. Correct functional dimerisation of two GHR molecules is essential for GH signalling. We have previously shown that membrane bound tru...

ea0011p246 | Cytokines and growth factors | ECE2006

GH and GH antagonist B2036 effect on the immune system

Maamra M , Perna F , Colao A , Pivonello R , Zappacosta S , Ross RJM , Matarese G

Introduction: Growth Hormone (GH) receptors are expressed on, and GH is secreted by, human peripheral blood mononuclear cells (PBMCs). However, the role of GH in immunity has remained elusive and studies have given conflicting results. Experimental data strongly implicates a role for pituitary GH in the immune response of rodents. The data from knockout mice suggests that GH acts not as an obligate immunoregulator but as an anabolic and stress-modulating hormone. Despite the c...